Global Advocacy: Progress Report
Melanoma is a global disease. In the United States, one person dies every 54 minutes from melanoma. Australia and New…
11/13/2018
Global Advocacy: Progress Report
Melanoma is a global disease. In the United States, one person dies every 54 minutes from melanoma. Australia and New…
|
11/13/2018
The Melanoma Tissue Bank: Progress Report
As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
|
|
10/08/2018
Grocery Shopping Tips for Melanoma Caregivers
Shop with a list: Make copies of a standard a grocery list that can be added to each week which includes…
|
09/05/2018
In Plain English: The Keynote 716 Clinical Trial
As of this writing, there are 477 clinical trials in melanoma on ClinicalTrial.gov that are actively recruiting patients—and another 65…
|
09/04/2018
Q&A With Three Leading Melanoma Specialists
Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
|
08/30/2018
Melanoma By The State: Vermont
Vermont is a state known for national and state forests, majestic snow-covered mountains, delicious maple syrup, and Ben and Jerry’s…
|
07/31/2018
AIM Announces New Partnership With The Society for Immunotherapy of Cancer (SITC)
AIM at Melanoma is proud to announce our new online educational partnership with the Society for Immunotherapy of Cancer…
|
07/03/2018
Melanoma By The State: Minnesota
Minnesota tops Midwest in melanoma incidences Minnesota has the third highest incidence rate of melanoma in the United States, tied with New…
|
06/27/2018
For Tracy Welge, The Cure is in The Bag
Meet Tracy Welge, a 41-year-old wife, mother, and melanoma survivor from Naperville, Illinois. Two melanoma diagnoses, an entrepreneurial spirit, and a…
|
|
04/27/2018
Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute
Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
|
Recent Posts
Apr. 16, 2024
Navigating the Journey Together – Conversations with Melanoma Caregivers
Apr. 12, 2024
May is Brain Tumor Awareness Month
Apr. 11, 2024
President’s Letter | April 2024
Apr. 11, 2024
Celebrating a Milestone: 20 Years of the Dallas Steps Against Melanoma Walk
Apr. 11, 2024